Ban Loong Holdings Limited logo

Ban Loong Holdings Limited (0030)

Market Closed
15 Jun, 08:00
HKEX HKEX
0. 23
HKD
+0.01
+5.5556%
HKD
1.82B Market Cap
- P/E Ratio
- Div Yield
646,000 Volume
- Eps
0.22 HKD
Previous Close
Add Transaction
Day Range
0.22 0.23
Year Range
0.18 0.32
Want to track 0030 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

0030 closed today higher at 0.23 HKD, an increase of 5.5556% from yesterday's close, completing a monthly increase of 22.5806% or 0.04 HKD. Over the past 12 months, 0030 stock lost -5%.
0030 is not paying dividends to its shareholders.
Ban Loong Holdings Limited has completed 1 stock splits, with the recent split occurring on Nov 18, 2016.
The company's stock is traded on one exchange.

0030 Chart

People also search for

Global Mastermind Capital Limited
0.18 HKD
-1.105%
Tian Tu Capital Co., Ltd.
1.97 HKD
0%
Sinohealth Holdings Ltd.
4.99 HKD
+5.2743%
Get Nice Holdings Limited
3.37 HKD
+2.4316%
IntelliCentrics Global Holdings Ltd.
4.06 HKD
-0.2457%

Ban Loong Holdings Limited (0030) FAQ

What is the stock price today?

The current price is 0.23 HKD.

On which exchange is it traded?

Ban Loong Holdings Limited is listed on HKEX.

What is its stock symbol?

The ticker symbol is 0030.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 1.82B.

Has Ban Loong Holdings Limited ever had a stock split?

Ban Loong Holdings Limited had 1 splits and the recent split was on Nov 18, 2016.

Ban Loong Holdings Limited Profile

Capital Markets Industry
Financials Sector
Mr. Ming Tang CEO
HKEX Exchange
BMG0865U1009 ISIN
Hong Kong Country
34 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

YNBY International Limited, initially known as Ban Loong Holdings Limited until its name change in September 2023, stands as a multifaceted investment holding company with a diverse portfolio. Positioned in Wan Chai, Hong Kong, it has carved a niche in various high-demand sectors, including money lending, trading of goods and commodities, and the burgeoning market of Cannabidiol isolates. Operating across vital international markets, including Hong Kong and the People's Republic of China, YNBY extends its reach globally, catering to an expansive client base. Its operations are segmented into Money Lending, where it offers short-term personal and corporate loans; Trading of Goods and Commodities, involving the trade of refined edible oil, sugar, cosmetic, cannabidiol, and personal care products; and the specialized segment of Cannabidiol isolate, positioning YNBY in the competitive health and wellness industry. A notable collaboration with Alpex Pharma SA underpins its strategic commitment towards the development and commercialization of nutraceutical products, marking a significant stride towards innovation and market expansion.

Products and Services

  • Money Lending: YNBY International Limited offers financing solutions encompassing short-term personal and corporate loans. This service is designed to meet the immediate financial needs of individuals and businesses, facilitating liquidity and capital flow within the market.
  • Trading of Goods and Commodities: The company's trading operations span a vast array of products including refined edible oil, which is a staple in both domestic and industrial cooking; sugar, a key ingredient in the food industry; cosmetic products, addressing the demand in beauty and skincare; and personal care products, catering to daily hygiene and wellness needs. Each category is carefully selected to ensure quality and relevance in today’s market.
  • Cannabidiol Isolate: Venturing into the health and wellness sector, YNBY's involvement with Cannabidiol isolate underscores its dedication to innovative, health-oriented products. Cannabidiol, or CBD, is known for its therapeutic properties, and the company’s focus on isolates ensures a pure, potent product offering for consumers seeking non-psychoactive health benefits.

Contact Information

Address: Cambridge House
Phone: 852 2549 8222